Latest Articles

Publication Date
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart

Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer Minichart

Published: May 14, 2026, 4:30 p.m.
Robert Irwin hails sister Bindi’s openness on endometriosis battle - MSN

Robert Irwin hails sister Bindi’s openness on endometriosis battle MSN

Published: May 14, 2026, 4:16 p.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise

Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise

Published: May 14, 2026, 12:40 p.m.
"My 30 year wait for an endometriosis diagnosis left me walking with a cane!" - ITVX

"My 30 year wait for an endometriosis diagnosis left me walking with a cane!" ITVX

Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment - Investing.com

Karyopharm completes endometrial cancer trial enrollment Investing.com

Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment By Investing.com - Investing.com Canada

Karyopharm completes endometrial cancer trial enrollment By Investing.com Investing.com Canada

Published: May 14, 2026, 11:45 a.m.
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M - Stock Titan

Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M Stock Titan

Published: May 14, 2026, 11:30 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire

Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire

Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo

Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo

Published: May 14, 2026, 11:30 a.m.
Endometriosis: A silent growing condition affecting women - Daily Monitor

Endometriosis: A silent growing condition affecting women Daily Monitor

Published: May 14, 2026, 9:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!